Prelude Therapeutics Incorporated Revenue and Competitors
Estimated Revenue & Valuation
- Prelude Therapeutics Incorporated's estimated annual revenue is currently $31.6M per year.
- Prelude Therapeutics Incorporated's estimated revenue per employee is $193,750
- Prelude Therapeutics Incorporated's total funding is $122M.
Employee Data
- Prelude Therapeutics Incorporated has 163 Employees.
- Prelude Therapeutics Incorporated grew their employee count by 9% last year.
Prelude Therapeutics Incorporated's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Legal Officer | Reveal Email/Phone |
4 | Executive Assistant to President and CMO | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | Chief People Officer | Reveal Email/Phone |
7 | President and Chief Medical Officer | Reveal Email/Phone |
8 | EVP & Head Chemistry | Reveal Email/Phone |
9 | VP, Head Development Program Leadership and Management | Reveal Email/Phone |
10 | VP and Head Process Chemistry, CMC | Reveal Email/Phone |
Prelude Therapeutics Incorporated Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $79.1M | 510 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 20% | N/A | N/A |
#3 | $1.9M | 12 | 9% | N/A | N/A |
#4 | $5.4M | 35 | 21% | N/A | N/A |
#5 | $0.8M | 5 | -29% | N/A | N/A |
#6 | $8.7M | 56 | 24% | N/A | N/A |
#7 | $1.4M | 9 | -31% | N/A | N/A |
#8 | $1.1M | 7 | 0% | N/A | N/A |
#9 | $36M | 232 | 19% | N/A | N/A |
#10 | $15.5M | 100 | -2% | N/A | N/A |
What Is Prelude Therapeutics Incorporated?
Prelude Therapeutics is a privately held biotechnology company focused on discovering and developing new medicines targeting chromatin function to treat cancer and rare diseases
keywords:N/A
$122M
Total Funding
163
Number of Employees
$31.6M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Prelude Therapeutics Incorporated News
2022-03-22 - Prelude Therapeutics Reports Full Year 2021 Financial Results
WILMINGTON, Del., March 16, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology...
2022-03-22 - Jane Huang, MD, Joins Prelude Therapeutics as President
WILMINGTON, Del., March 09, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) a clinical-stage precision oncology...
Other Companies in Wilmington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $25.1M | 163 | -13% | N/A |
#2 | $47.9M | 165 | -21% | N/A |
#3 | $43.4M | 165 | N/A | N/A |
#4 | $49.9M | 168 | 4% | N/A |
#5 | $27.1M | 170 | 22% | N/A |